|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 3, 823-835, March 2003
Department of Molecular Biology, Cell Biology, and
Biochemistry, Brown University, Providence, Rhode Island 02912
c-myc is an important protooncogene whose
misregulation is believed to causally affect the development of
numerous human cancers. c-myc null rat fibroblasts are
viable but display a severe (two- to threefold) retardation of
proliferation. The rates of RNA and protein synthesis are reduced by
approximately the same factor, whereas cell size remains unaffected. We
have performed a detailed kinetic cell cycle analysis of
c-myc
/
cells by using several labeling
and synchronization methods. The majority of cells (>90%) in
asynchronous, exponential phase c-myc
/
cultures cycle continuously with uniformly elongated cell cycles. Cell
cycle elongation is due to a major lengthening of G1 phase (four- to fivefold) and a more limited lengthening of G2
phase (twofold), whereas S phase duration is largely unaffected.
Progression from mitosis to the G1 restriction point and the subsequent
progression from the restriction point into S phase are both
drastically delayed. These results are best explained by a model in
which c-Myc directly affects cell growth (accumulation of mass) and
cell proliferation (the cell cycle machinery) by independent pathways.
This article has been cited by other articles:
![]() |
M. Verykokakis, C. Papadaki, E. Vorgia, L. Le Gallic, and G. Mavrothalassitis The RAS-dependent ERF Control of Cell Proliferation and Differentiation Is Mediated by c-Myc Repression J. Biol. Chem., October 12, 2007; 282(41): 30285 - 30294. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumar, M. Marques, and A. C. Carrera Phosphoinositide 3-Kinase Activation in Late G1 Is Required for c-Myc Stabilization and S Phase Entry Mol. Cell. Biol., December 1, 2006; 26(23): 9116 - 9125. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lu, C. D. Wolfgang, and T. Hai Activating Transcription Factor 3, a Stress-inducible Gene, Suppresses Ras-stimulated Tumorigenesis J. Biol. Chem., April 14, 2006; 281(15): 10473 - 10481. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Rogulski, D. E. Cohen, D. L. Corcoran, P. V. Benos, and E. V. Prochownik Deregulation of common genes by c-Myc and its direct target, MT-MC1 PNAS, December 27, 2005; 102(52): 18968 - 18973. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Walker, Z.-Q. Zhou, S. Ota, A. Wynshaw-Boris, and P. J. Hurlin Mnt-Max to Myc-Max complex switching regulates cell cycle entry J. Cell Biol., May 9, 2005; 169(3): 405 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, S.-i. Tsukumo, N. Suzuki, H. Motohashi, M. Yamamoto, Y. Fujii-Kuriyama, J. Mimura, T.-M. Lin, R. E. Peterson, C. Tohyama, et al. A Constitutively Active Arylhydrocarbon Receptor Induces Growth Inhibition of Jurkat T Cells through Changes in the Expression of Genes Related to Apoptosis and Cell Cycle Arrest J. Biol. Chem., June 11, 2004; 279(24): 25204 - 25210. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Hendricks, F. Shanahan, and E. Lees Role for BRG1 in Cell Cycle Control and Tumor Suppression Mol. Cell. Biol., January 1, 2004; 24(1): 362 - 376. [Abstract] [Full Text] [PDF] |
||||